Infusion-related events during natalizumab: No need for post-infusion monitoring

This retrospective cohort study assessed the timing of infusion-related adverse events (IAEs) during natalizumab (NTZ) administration in well-documented relapsing-remitting multiple sclerosis (RRMS) patients who had received NTZ infusions in our centre between 2006 and 2018. In 225 RRMS patients (14...

Descripción completa

Detalles Bibliográficos
Autores principales: Loonstra, Floor C, van Rossum, Johannis A, van Kempen, Zoé LE, Rispens, Theo, Uitdehaag, Bernard MJ, Killestein, Joep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575291/
https://www.ncbi.nlm.nih.gov/pubmed/31237826
http://dx.doi.org/10.1177/1352458519860415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575291/
https://www.ncbi.nlm.nih.gov/pubmed/31237826
http://dx.doi.org/10.1177/1352458519860415

Ejemplares similares